TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways
Abstract
Share and Cite
Yoon, J.-J.; Tai, A.-L.; Kim, H.-Y.; Han, B.-H.; Shin, S.; Lee, H.-S.; Kang, D.-G. TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways. Int. J. Mol. Sci. 2024, 25, 10573. https://doi.org/10.3390/ijms251910573
Yoon J-J, Tai A-L, Kim H-Y, Han B-H, Shin S, Lee H-S, Kang D-G. TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways. International Journal of Molecular Sciences. 2024; 25(19):10573. https://doi.org/10.3390/ijms251910573
Chicago/Turabian StyleYoon, Jung-Joo, Ai-Lin Tai, Hye-Yoom Kim, Byung-Hyuk Han, Sarah Shin, Ho-Sub Lee, and Dae-Gill Kang. 2024. "TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways" International Journal of Molecular Sciences 25, no. 19: 10573. https://doi.org/10.3390/ijms251910573